Process for production of piperidine derivatives

Details Process for production of piperidine derivatives Process for production of piperidine derivatives

1995-12-21

2000-11-28

Chang, Ceila

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

546209, 546210, 546216, 546240, 548146, 548187, 548230, 548237, 5483225, 5483501, C07D21134

Patent

active

061537543

ABSTRACT:
The present invention relates to a method for preparing piperidine derivative compounds by converting, with a piperidine compound, regioisomers having the formula: ##STR1## where Z is --CG.sup.1 G.sup.2 G.sup.3, ##STR2## and where m is an integer from 1 to 6; Q and Y are the same or different and are selected from the group consisting of O, S, and NR.sup.5 ; G.sup.1, G.sup.2, and G.sup.3 are the same or different and are selected from the group consisting of OR.sup.8, SR.sup.8, and NR.sup.8 R.sup.9 ; and R.sup.5, R.sup.8, and R.sup.9 are the same or different and are selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety.

REFERENCES:
patent: 2919274 (1959-12-01), Faust et al.
patent: 3687956 (1972-08-01), Zivkovic
patent: 3806526 (1974-04-01), Carr et al.
patent: 3829433 (1974-08-01), Carr et al.
patent: 3839431 (1974-10-01), Sheehan et al.
patent: 3862173 (1975-01-01), Carr et al.
patent: 3878217 (1975-04-01), Carr et al.
patent: 3898271 (1975-08-01), Sheehan et al.
patent: 3922276 (1975-11-01), Duncan et al.
patent: 3931197 (1976-01-01), Carr et al.
patent: 3941795 (1976-03-01), Carr et al.
patent: 3946022 (1976-03-01), Carr et al.
patent: 3956296 (1976-05-01), Duncan et al.
patent: 3965257 (1976-06-01), Carr et al.
patent: 4028404 (1977-07-01), Bays et al.
patent: 4254129 (1981-03-01), Carr et al.
patent: 4254130 (1981-03-01), Carr et al.
patent: 4285957 (1981-08-01), Carr et al.
patent: 4285958 (1981-08-01), Carr et al.
patent: 4407823 (1983-10-01), Kirsch et al.
patent: 4550116 (1985-10-01), Soto et al.
patent: 4742175 (1988-05-01), Fawcett et al.
patent: 5375693 (1994-12-01), Woosley et al.
patent: 5578610 (1996-11-01), D'Ambra
patent: 5581011 (1996-12-01), D'Ambra
Neubold "Cyclic imido acid esters" Ca 79:92196, 1973.
Boell et al. "2-Pyridinols" CA 90:6252, 1978.
Caujolle et al. "Synthesis antiparasitic and antifungal activities of arylalkyl and arylvinylthiazolines" CA 119:139162, 1993.
Clarke et al. "A facile one stage synthesis of oxazolines under microwave irradiation" CA 124:317042, 1996.
Murugesan et al. "Preparation of N-isoxazolylbiphenylsulfonamides as endothelin antagonists" CA 125:10795, 1996.
Busacca et al. "A one step synthesis of thiazolines from esters" Ca 125:58380, 1996.
Meyers, A.I. et al, "Synthesis via Oxazolines. A Highly Stereoselective Synthesis of (+/-)-cis-2-Methyl Cyclopentanecarboxylic Acid, vvia a Kinetically Controlled Cyclization" J.C.S. Chem. Comm. 1974, pp. 768-770.
Swain, C.J. et al, "Novel 5-HT3 Antagonists: Indol-3-yllspiro(azabicycloalkane-3,5'(4'H)oxazoles)" J. Med. Chem. 1992, 35(6), pp. 1019-1031, abstract only.
Meyers et al., "Oxazolines. IX. Synthesis of Homologated Acetic Acids and Esters," J. Org. Chem., 39:2778-2783 (1974).
Meyers et al., "Oxazolines. X. Synthesis of .gamma.-Butyrolactones," J. Org. Chem., 39:2783-2787 (1984).
Meyers et al., "Oxazolines. XI. Synthesis of Functionalized Aromatic and Aliphatic Acids. A Useful Protecting Group for Carboxylic Acids against Grignard and Hydride Reagents," J. Org. Chem., 39:2787-2793 (1974).
Milstein et al., "A General, Selective, and Facile Method for Ketone Synthesis from Acid Chlorides and Organotin Compounds Catalyzed by Palladium," Journal of the American Chemical Society, 100:3636-3638 (1978).
Milstein et al., "Mild, Selective, General Method of Ketone Synthesis from Acid Chlorides and Organotin Compounds Catalyzed by Palladium," J. Org. Chem., 44:1613-1618 (1979).
March, Advanced Organic Chemistry: Reactions, Mechanisms, and Structure, 4th Ed., New York: John Wiley & Sons, pp. 478-479 and 661-662 (1992).
Swain et al., "Novel 5-HT, Antagonists: Indol-3-ylspiro(azabicycloalkane-3,5'(4'H)-oxazoles)," Journal of Medicinal Chemistry, 35:1019-1031 (1992).
Fishwick et al., "An Efficient Route to S-N-(9-Fluorenylmethoxycarbonyl)-4'-(1-azi-2,2,2-trifjuoroethyl)phenylalan ine," Tetrahedron Letters, 35:4611-4614 (1994).
K.Y. Chan, et al., "Direct enantiomeric separation of terfenadine and its major acid metabolite by high-performance liquid chromatography, and the lack of stereoselective terfenadine enantiomer biotransformation in man," Journal of Chromatography, 271:291-97 (1991).
F.J. McCarty, et al., "Central Depressants. Phosphoramidates Derived from .alpha.,.alpha.-Disubstituted 4-Piperidinemethanols," Department of Organic Research, Scientific Laboratories, (1961).
Chemical Abstract, vol. 94, 1981, pp. 644, 94:156758e.
Chemical Abstract, vol. 110, 1989, pp. 762, 110:173097e.
Woosley, R.L., et al. "Mechanism of the Cardiotoxic Actions of Terfenadine," JAMA 269 (12):1532-36 (Mar. 1993).
Honig, P.K., et al. "Terfenadine-ketoconazole Interaction. Pharmacokinetic and Electrocardiographic Consequences," JAMA, 269 (12):1513-18 (Mar. 1993).
Kuhlman, J.J., Jr., "Measurement of Azacyclonol in Urine and Serum of Humans Following Terfenadine (Seldane) Administration Using Gas Chromatography-mass Spectrometry," J. Chromatogr. 578 (2):207-13 (Jul. 1992).
Honig, P.K., et al., "Changes in the Pharmacokinetics and Electrocardiographic Pharmacodynamics of Terfenadine with Concomitant Administration of Erythromycin," Clin. Pharmacol. Ther. 52(3): 231-8 (Sep. 1992).
Chen, T.M., et al., "Determination of the Metabolites of Terfenadine in Human Urine by Thermospray Liquid Chromatography-Mass Spectrometry," J. Pharm. Biomed. Anal. 9(10-12):929-33, (1991).
Zamani, K., et al., "Enantiomeric Analysis of Terfenadine in Rat Plasma by HPLC," Chirality, 3(6):467-70 (1991).
Eller, M.G., et al., "Absence of Food Effects on the Pharmacokinetics of Terfenadine," Biopharm. Drug Dispos. 13(3):171-7 (Apr. 1992).
Chan, K.Y., "Direct Enantiomeric Separation of Terfenadine and its Major Acid Metabolite by High-Performance Liquid Chromatography, and the Lack of Stereoselective Terfenadine Enantiomer Biotransformation in Man," J. Chromatogr. 571(1-2) 291-7 (1991).
Eller, M.G., et al., "Pharmacokinetics of Terfenadine in Healthy Elderly Subjects," J. Clin. Pharmacol. 32(3):267-71 (Mar. 1992).
Coutant, J.E., et al. "Determination of Terfenadine and Terfenadine Acid Metabolite in Plasma using Solid-Phase Extraction and High-Performance Liquid Chromatography with Fluorescence Detection," J. Chromatogr. 570(1):139-48 (1991).
Luo, H., et al. "N(+)-glucuronidation of Aliphatic Tertiary Mines, A General Phenomenon in the Metabolism of H1-antihistamines in Humans," Xenobiotca., 21(10):1281-8 (Oct. 1991).
Estelle, F., et al., "Pharmacokinetic Optimisation of Histamine H1-Receptor Antagonist Therapy," Clin. Pharmacokinet., 21(5):372-93 (Nov. 1991).
Shall, L. et al., "Dose-Response Relationship Between Objective Measures of Histamine-Induced Weals and Dose of Terfenadine," Acta. Derm. Venereol. 71(3):199-204 (1991).
Campoli-Richards, D.M., et al., "Cetirizine. A Review of its Pharmacological Properties and Clinical Potential in Allergic Rhinitis, Pollen-Induced Asthma, and Chronic Urticaria," Drugs 40(5)762-81 (Nov. 1990).
Snowman, A.M., et al., "Cetirizine: Actions on Neurotransmitter Receptors," J. Allergy Clin. Immunol. 86(6-2)1025-8 (Dec. 1990).
Berman, B.D., "Perennial Allergic Rhinitis: Clinical Efficacy of a New Antihistamine," J. Allergy Clin. Immunol. 86 (68-2)1004-(Dec. 1990).
Monahan, B.P., et al., "Torsades de Pointes Occurring in Association with Terfenadine Use," JAMA, 264(21) 2788-90 (Dec. 1990).
Simons, K.J., et al., "Pharmacokinetics and Pharmacodynamics of Terfenadine and Chlorpheniramine In the Elderly," J. Allergy Clin. Immunol. 85(3)540-7 (Mar. 1990).
Sweeney, G.D., et al., "Anti-Allergy and Anti-Asthma Drugs. Disposition in Infancy and Childhood," Clin. Pharmacokinet, 17 Suppl (1):156-68 (1989).
Coniglio, A.A., "Effect of Acute and Chronic Terfenadine on Free and Total Serum Phenytoin Concentrations in Epileptic Patients," Epilepsia 39(5):611-6 (Sep.-Oct. 1989).
Mann, K.V., et al., "Nonsedating Histamine H1-Receptor Antagonists," Clin. Pharm. 8(5):331-44 (May 1898).
Barenhotz, H.A., "Loratadine: A Non Sedating Antihistamine with Once-Daily Dosing," DICP 23(6):44550 (Jun. 1989).
Brion, N., et al., "Lack of Effect of Terfenadine on Theophylline Pharmacokinetics and Metabolism in Normal

Affiliated with

Also associated with

Rating

Process for production of piperidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for production of piperidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for production of piperidine derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1727070